Tumorigenicity of polycyclic aromatic hydrocarbons: “On the possible contribution of PAHs and their nitro-derivatives to the development of human breast cancer”

The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons

Volumn , Issue , 2005, Pages 315-351

  Amin, Shantu ^a   El Bayoumy, Karam ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751231212     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860949333_0009     Document Type: Chapter

References (136)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ (2003) Cancer Statistics, 2003. CA Cancer J. Clin. 53: 5-26.
2. WHO (1997) The World Health Report. World Health Organization, Geneva.
3. Willett WC (1995) Diet, nutrition, and avoidable cancer. Environ. Health Perspect. 103, Suppl 8: 165-170.
4. Kelsey JL and Bernstein L (1996) Epidemiology and prevention of breast cancer. Annu. Rev. Public Health 17: 47-67.
5. Henderson IC (1993) Risk factors for breast cancer development. Cancer 11: 2127-2140.
6. Service RF (1998) New role for estrogen in cancer? Science 279:1631-1633.
7. Bennett IC, Gattas M and Teh BT (1999) The genetic basis of breast cancer and its clinical implications. Aust. N.Z. J. Surg. 69: 95-105.
8. Jeffy BD, Chimomas RB and Romagnolo DF (2002) Epigenetics of breast cancer: polycyclic aromatic hydrocarbons as risk factors. Environ. Mol. Mutagen. 39: 235-244.
9. Cohen LA, Rose DP and Wynder EL (1993) A rationale for dietary intervention in postmenopausal breast cancer patients: an update. Nutr. Cancer 19: 1-10.
10. Doll R (1996) Nature and nurture: possibilities for cancer control (Commentary). Carcinogenesis 17: 177-184.
11. Lipworth L (1995) Epidemiology of breast cancer. Eur. J. Cancer Prev. 4: 7-30.
12. Willett WC, Coldnitz GA and Mueller N (1996) Strategies for minimizing cancer risk. Sci. Am. 88-95.
13. Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT and Blackburn G (1997) Breast cancer: weighing the evidence for a promoting role of dietary fat. J. Natl. Cancer Inst. 89: 766-775.
14. Laurence DJ, Monaghan P and Gusterson BA (1991) The development of the normal human breast. Oxf. Rev. Reprod. Biol. 13: 149-174.
15. McManus MJ and Welsch CW (1981) Hormone-induced ductal DNA synthesis of human breast tissues maintained in the athymic nude mouse. Cancer Res. 41: 3300-3305.
16. Wright WC (1940) Translation of: De Morbis Artificium Diatriba (‘Diseases of Workers’, originally published in 1713 by Bernardino Ramazzini) University of Chicago Press, Chicago.
17. Russo J and Russo IH (1999) Cellular basis of breast cancer susceptibility. Oncol. Res. 11: 169-178.
18. El-Bayoumy K (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem. Res. Toxicol. 5: 585-590.
19. Fung VA, Huff J, Weisburger EK and Hoel DG (1993) Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fundam. Appl. Toxicol. 20: 413-436.
20. Moms JJ and Seifter E (1992) The role of aromatic hydrocarbons in the genesis of breast cancer. Med. Hypoth. 38: 177-184.
21. Morton WE (1995) Major differences in breast cancer risks among occupations. J. Occup. Environ. Med. 37: 328-335.
22. Weiderpass E, Pukkala E, Kauppinen T, Mutanen P, Paakkulainen H, Vasama-Neuvonen K, Boffetta P and Partanen T (1999) Breast cancer and occupational exposures in women in Finland. Am. J. Ind. Med. 36: 48-53.
23. Welp EA, Weiderpass E, Boffetta P, Vainio H, Vasama-Neuvonen K, Petralia S and Partanen TJ (1998) Environmental risk factors of breast cancer. Scand. J. Work Environ. Health 24: 3-7.
24. Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H and Nishimori I (1987) Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat. Res. 112: 243-272.
25. Terry PD and Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol. Biomarkers Prev. 11: 953-971.
26. MorabiaA (2002) Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001. Environ. Mol. Mutagen. 39: 89-95.
27. Petrakis NL, Gruen LD, Beelen TC, Castagnoli N Jr and Craig JC (1978) Nicotine in breast fluid of non-lactating women. Science 199: 303-305.
28. Hecht SS (2002) Tobacco smoke carcinogens and breast cancer. Environ. Mol. Mutagen. 39: 119-126.
29. Beer A and Billingham RE (1978) Adipose tissue, a neglected factor in etiology of breast cancer. Lancet 2: 296.
30. Martin RL, Carmichael PL, Crofton-Sleigh C, Venitt S, Phillips DH and Grover PL (1996) Genotoxicity of human mammary lipid. Cancer Res. 56: 5342-5346.
31. Petrakis NL, Maack CA, Lee RE and Lyon M (1980) Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res. 40: 188-189.
32. Klein PM and Lawrence JA (2002) Lavage and nipple aspiration of breast ductal fluids: a source ofbiomarkers for environmental mutagenesis. Environ. Mol. Mutagen. 39: 127-133.
33. Scott WN and Miller WR (1991) Mutagens in human breast cyst fluid. J. Cancer Res. Clin. Oncol. 117: 254-258.
34. Thompson PA, DeMarini DM, Kadlubar FF, McClure GY, Brooks LR, Green BL, Fares MY, Stone A, Josephy PD and Ambrosone CB (2002) Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ. Mol. Mutagen. 39: 134-142.
35. Martin FL, Venitt S, Carmichael PL, Crofton-Sleigh C, Stone EM, Cole KJ, Gusterson BA, Grover PL and Phillips DH (1997) DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts. Carcinogenesis 18: 2299-2305.
36. Martin FL, Cole KJ, Weaver G, Williams JA, Millar BC, Grover PL and Phillips DH (1999) Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk. Biochem. Biophys. Res. Commun. 259: 319-326.
37. Martin FL, Cole KJ, Harvey DP, Weaver G, Williams JA, Millar BC, Phillips DH and Grover PL (2000) DNA damage in human breast milk cells and its induction by ‘early’ and ‘late’ milk extracts. Carcinogenesis 21:799-804.
38. Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB and Kadlubar FF (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ. Mol. Mutagen. 39: 184-192.
39. Li D, Wang M, Dhingra K and Hittleman WN (1996) Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res. 56: 287-293.
40. Li D, Wang M, Firozi PF, Chang P, Zhang W, Baer-Dubowska W, Moorthy B, Vulimiri SV, Goth-Goldstein R, Weyand EH and DiGiovanni J (2002) Characterization of a major aromatic DNA adduct detected in human breast tissues. Environ. Mol. Mutagen. 39: 193-200.
41. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R and Phillips DH (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol. Biomarkers Prev. 4: 233-238.
42. Pfau W, Stone EM, Brockstedt U, Carmichael PL, Marquardt H and Phillips DH (1998) DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NATl genotypes. Cancer Epidemiol. Biomarkers Prev. 7: 1019-1025.
43. Rundle A, Tang D, Hibshoosh H, Schnabel F, Kelly A, Levine R, Zhou J, T-ink B and Perera F (2002) Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer. Environ. Mol. Mutagen. 39: 201-207.
44. 32P-postlabelling analysis of DNA adducts in human and rat mammary epithelial cells. Carcinogenesis 9: 1071-1072.
45. Wang M, Dhingra K, Hittleman WN, Liehr JG, de Andrade M and Li D (1996) Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol. Biomarkers Prev. 5: 705-710.
46. Boyiri, T, Guttenplan J, Khmelnitsky M, Kosinska W, Desai D, Pittman B and El-Bayoumy K (2003) Mammary carcinogenesis and mutations in the ell gene of lacIXCD transgenic rats induced by the environmental pollutant 6-nitrochrysene. Proc. Am. Assoc. Cancer Res. 44: 786, Abstract # 3440.
47. Manjanatha MG, Shelton SD, Cullp SJ, Blankenship LR and Casciano DA (2000) DNA adduct formation and molecular analysis of in vivo lacl mutations in the mammary tissue of Big Blue® rats treated with 7,12- dimethylbenz[a]anthracene. Carcinogenesis 21: 265-273.
48. Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL, Britton JA, Terry MB, Levin B, Stellman SD, Kabat GC, Hatch M, Senie R, Berkowitz G, Bradlow HL, Garbowski G, Maffeo C, Montalvan P, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V, Niguidula N, Ireland K and Santella RM (2002) Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol. Biomarkers Prev. 11: 686-697.
49. Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S and Vinceguerra V (2002) Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol. Biomarkers Prev. 11: 677-685.
50. Perera F and Rundle A (2003) Correspondence re: Gammon et al, Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol. Biomarkers Prev. 12:75-76.
51. Phillips DH (1983) Fifty years of benzo[a]pyrene. Nature 303: 468-472.
52. Phillips DH (1999) Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 443: 139-147.
53. Feilberg A, Poulsen MWB, Nielsen T and Skov H (2000) Occurrence and sources of particulate nitro-polycyclic aromatic hydrocarbons in ambient air in Denmark. Atmos. Environ. 35: 353-366.
54. Harvey RG (1991) Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenicity. Cambridge University Press, Cambridge, UK.
55. IARC (1983) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 32: Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, pp 37-38. International Agency for Research on Cancer, Lyon, France.
56. IARC (1983) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 32: Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, pp 95-451. International Agency for Research on Cancer, Lyon, France.
57. IARC (1983) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 32: Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, p 47. International Agency for Research on Cancer, Lyon, France.
58. IARC (1983) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 32: Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, pp 41-42. International Agency for Research on Cancer, Lyon, France.
59. IARC (1983) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 32: Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, pp 44-45. International Agency for Research on Cancer, Lyon, France.
60. Lijinsky W, Domsky I, Mason G, Ramahi HY and Safavi T (1963) The chromatographic determination of trace amounts of polynuclear hydrocarbons in petrolatum, mineral oil, and coal tar. Anal. Chem. 35: 952-956.
61. Mumford JL, Harris DB and Williams K (1987) Indoor air sampling and mutpgenicity studies of emissions from unvented coal combustion. Environ. Sci. Technol. 21: 308-311.
62. Cavalieri EL, Rogan E and Sinha D (1988) Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J. Cancer Res. Clin. Oncol. 114: 3-9.
63. Cavalieri EL, Rogan EG, Higginbotham S and Cremonesi P (1989) Tumor- initiating activity in mouse skin and carcinogenicity in rat mammary gland of dibenzo[a]pyrenes: the very potent environmental carcinogen dibenzo[a,l]- pyrene. J. Cancer Res. Clin. Oncol. 115: 67-72.
64. Cavalieri EL, Higginbotham S, RamaKrishna NVS, Devanesan PD, Todorovic R, Rogan EG and Salmasi S (1991) Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]• anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 12: 1939-1944.
65. Huggins C and Yang NC (1962) Induction and extinction of mammary cancer. Science 137: 257-262.
66. Pataki J and Huggins C (1969) Molecular site of substituents of benz[a]- anthracene related to carcinogenicity. Cancer Res. 29: 506-509.
67. Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. GHA Clowes Memorial Lecture. Cancer Res. 42: 4875-4917.
68. Gelboin HV (1980) Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed function oxidases and related enzymes. Physiol. Rev. 60: 1107-1166.
69. Jeffrey AM, Jennette KW, Blobstein SH, Weinstein IB, Beland FA, Harvey RG, Kasai H, Miura I and Nakanishi K (1976) Benzo[a]pyrene- nucleic acid derivative found in vivo: structure of a benzo[a]pyrene- tetrahydrodiol epoxide-guanosine adduct. J. Am. Chem. Soc. 98:5714-5715.
70. Thakker DR, Yagi H, Lu AYH, Levin W, Conney AH and Jerina DM (1976) Metabolism of benzo[a]pyrene: conversion of (±)-trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides. Proc. Natl. Acad. Sci. USA 73: 3381-3385.
71. Yang SK, McCourt DW, Roller PP and Gelboin HV (1976) Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene through a single enantiomer of r-7,t-8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 73, 2594-2598.
72. Cavalieri EL and Rogan EG (1995) Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25: 677-688.
73. Chen L, Devanesan PD, Higginbotham S, Ariese F, Jankowiak R, Small GJ, Rogan EG and Cavalieri E (1996) Expanded analysis of benzo[a]pyrene- DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chem. Res. Toxicol. 9: 897-903.
74. Penning TM, Oshnishi ST, Ohnishi T and Harvey RG (1996) Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol. 9: 84-92.
75. Penning TM, Burczynski ME, Hung CF, McCoull KD, Palackal NT and Tsuruda LS (1999) Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem. Res. Toxicol. 12: 1-18.
76. Shou M, Harvey RG and Penning TM (1992) Contribution of dihydrodiol dehydrogenase to the metabolism of (±)-trans-7,8-dihydroxy- 7,8- dihydrobenzo[a]pyrene in fortified rat liver subcellular fractions. Carcinogenesis 13: 1575-1582.
77. Smithgall TE, Harvey RG and Penning TM (1988) Spectroscopic identification of ortho-quinones as the products of polycyclic aromatic trans- dihydrodiol oxidation catalyzed by dihydrodiol dehydrogenase. A potential route of proximate carcinogen metabolism. J. Biol. Chem. 263: 1814-1820.
78. Angerer J, Mannschreck C and Gundel J (1997) Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons. Int. Arch. Occup. Environ. Health 70: 365-377.
79. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK and Yu MC (2001) Gender- and smoking-related bladder cancer risk. J. Natl. Cancer Inst. 93: 538-545.
80. El-Bayoumy K, Donahue JM, Hecht SS and Hoffmann D (1986) Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res. 46: 6064-6067.
81. 32P-postlabeling for the detection of DNA adducts. In: Technologies for the Detection of DNA Damage and Mutation [Pfeifer GP (ed.)] pp 45-61, Plenum Press, New York.
82. Kaderlik KR and Kadlubar FF (1995) Metabolic polymorphisms and car- cinogen-DNA adduct formation in human populations. Pharmacogenetics 5: S108-S117.
83. Kriek E, Rojas M, Alexandrov K and Bartsch H (1998) Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res. 400: 215-231.
84. Phillips DH (1996) DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ. Health Perspect. 104, Suppl 5: 453-458.
85. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV and Turteltaub KW (2000) Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ. Mol. Mutagen. 35: 222-233.
86. Poirier MC, Santella RM and Weston A (2000) Carcinogen maeromoleeular adducts and their measurement. Carcinogenesis 21: 353-359.
87. Santella R (1999) Immunological methods for detection of carcinogen-DNA damage in humans. Cancer Epidemiol. Biomarkers Prev. 8: 733-739.
88. Skipper PL and Tannenbaum SR (1990) Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11: 507-518.
89. Skipper PL, Peng X, SooHoo CK and Tannenbaum SR (1994) Protein adducts as biomarkers of human carcinogen exposure. Drug Metab. Rev. 26:111-124.
90. Boysen G and Hecht SS (2003) Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat. Res. 543: 17-30.
91. Chen M, Carmella SG, Yagi H, Jerina DM and Hecht SS (2003) Quantitation of r-l,t-2,3,c-4-tetrahydroxy-l,2,3,4-tetrahydrophenanthrene (PT) in human urine: an approach to phenotying the polycyclic aromatic hydrocarbon (PAH) diol epoxide pathway. Proc. Am. Assoc. Cancer Res. 44: 1469, Abstract #6412.
92. King CM, Traub NR, Lortz ZM and Thissen MR (1979) Metabolic activation of arylhydroxamic acids by N-O-acyl tran sferase of rat mammary gland. Cancer Res. 39: 3369-3372.
93. Moore CJ, Eldridge SR, Tricomi WA and Gould MN (1987) Quantitation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells. Cancer Res. 47: 2609-2613.
94. Stampfer MR, Bartholomew JC, Smith HS and Bartley JC (1981) Metabolism of benzo[a]pyrene by human mammary epithelial cells: toxicity and DNA adduct formation. Proc. Natl. Acad. Sci. USA 78: 6251-6255.
95. Carmichael PL, Stone EM, Grover PL, Gusterson BA and Phillips DH (1996) Metabolic activation and DNA binding of food mutagens and other environmental carcinogens in human mammary epithelial cells. Carcinogenesis 17: 1769-1772.
96. Melendez-Colon VJ, Smith CA, Seidel A, Luch A, Platt KL and Baird WM (1997) Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a, l]pyrene or its diol epoxides. Proc. Natl. Acad. Sci. USA 94: 13542-13547.
97. Agarwal R, Coffing SL, Baird WM, Kiselyov AS, Harvey RG and Dipple A (1997) Metabolic activation of benzo[g]chrysene in the human mammary carcinoma cell line MCF-7. Cancer Res. 57: 415-419.
98. Einolf HJ, Amin S, Yagi H, Jerina DM and Baird WM (1996) Benzo[c]- phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skin. Carcinogenesis 17: 2237-2244.
99. Einolf HJ, Story WT, Marcus CB, Larsen MC, Jefcoate CR, Greenlee WF, Yagi H, Jerina DM, Amin S, Park SS, Gelboin HV and Baird WM (1997) Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis. Chem. Res. Toxicol. 10: 609-617.
100. Singletary K and MacDonald C (2000) Inhibition of benzo[a]pyrene- and 1,6-dinitropyrene-DNA adduct formation in human mammary epithelial cells by dibenzoylmethane and sulforaphane. Cancer Lett. 155: 47-54.
101. Caruso JA, Reiners JJ Jr, Emond J, Shultz T, Tainsky MA and Alaoui-Jamali M (2001) Genetic alteration of chromosome 8 is a common feature of human mammary epithelial cell lines transformed in vitro with benzo[a]pyrene. Mutat. Res. 473: 85-99.
102. Pitts JN Jr, van Cauwenberghe KA, Frosjean D, Schmidt JP, Fitz DR, Belser WL, Knudson GB and Nynds PM (1978) Atmospheric reaction of polycyclic aromatic hydrocarbons: facile formation of mutagenic nitro derivatives. Science 202: 515-519.
103. Jäger J (1978) Detection and characterization of nitro derivatives of some polycyclic aromatic hydrocarbons by fluorescence quenching after thin-layer chromatography: application to air pollution analysis. J. Chromatogr. 152: 575-578.
104. Kielhom J, Wahnschaffe U and Mangelsdorf I (2003) A Report: Selected Nitro- and Nitro-oxy-polycyclic Aromatic Hydrocarbons. The World Health Organization 2003, Environmental Health Criteria 229.
105. Fu PP and Herreno-Saenz D (1999) Nitro-polycyclic aromatic hydrocarbons: a class of genotoxic environmental pollutants. Environ. Carcinog. Ecotox. Rev. C17: 1-43.
106. Tokiwa H, Sera N, Horikawa K, Nakanishi Y and Shigematu N (1993) The presence of mutagens/carcinogens in the excised lung and analysis of lung cancer induction. Carcinogenesis 14: 1933-1938.
107. Zwimer-Baier I and Neumann HG (1999) Genetic toxicology and environmental mutagenesis. Mutat. Res. 441: 135-144.
108. El-Bayoumy K, Johnson BE, Roy AK, Upadhyaya P and Partian SJ (1994) Biomonitoring of Nitropolynuclear Aromatic Hydrocarbons via Protein and DNA Adducts. Research Report Number 64, April, Health Effects Institute, Boston, MA, USA.
109. Bamford HA, Bezabeh DZ, Schantz MM, Wise SA and Baker JE (2003) Determination and comparison of nitrated-polycyclic aromatic hydrocarbons measured in air and diesel particulate reference materials. Chemosphere 50: 575-587.
110. Feilberg A, Ohura T, Nielsen T, Poulsen MWB and Amagai T (2002) Occurrence and photostability of 3-nitrobenzanthrone associated with atmospheric particles. Atmos. Environ. 36: 3591-3600.
111. IARC (1989) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 46: Diesel and Gasoline Engine Exhausts and Some Nitroarenes, pp 189-373. International Agency for Research on Cancer, Lyon, France.
112. IARC (1989) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 46: Diesel and Gasoline Engine Exhausts and Some Nitroarenes, p 53. International Agency for Research on Cancer, Lyon, France.
113. IARC (1996) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 65: Printing Process and Printing Inks, Carbon Black and some Nitro Compounds, p 297. International Agency for Research on Cancer, Lyon, France.
114. Ishii S, Hisamatsu Y, Inazu K and Aika KI (2001) Environmental occurrence of nitrotriphenylene observed in airborne particulate matter. Chemosphere 44: 681-690.
115. Malejka-Giganti D, Niehans GA, Reichert MA, Bennett KK and Bliss RL (1999) Potent carcinogenicity of 2,7-dinitrofluorene, an environmental pollutant, for the mammary gland of female Sprague-Dawley rats. Carcinogenesis 20: 2017-2023.
116. Matshushita H and Lida Y (1986) Application of capillary gas chromatography to environmental analysis. High Res. Chromat. & Chromat. Commun. 9: 708-711.
117. NTP (1998) Eighth Report on Carcinogens. National Toxicology Program, U.S. Department of Health and Human Services.
118. Hecht SS and El-Bayoumy K (1990) The possible role of nitroarenes in human cancer. In: Nitroarenes: The Occurrence, Metabolism, and Biological Impact of Nitroarenes [Howard PC, Hecht SS and Beland FA (eds.)] pp 309-316, Plenum Press, New York.
119. Amin S, Lin JM, Krzeminski J, Boyiri T, Desai D and El-Bayoumy K (2003) Metabolism of benzo[c]chrysene and comparative mammary gland tumorigenesis of benzo[c]chrysene bay and fjord region diol epoxides in female CD rats. Chem. Res. Toxicol. 16: 227-231.
120. El-Bayoumy K, Rivenson A, Johnson B, DiBello J, Little P and Hecht SS (1988) Comparative tumorigenicity of 1-nitropyrene, 1-nitrosopyrene, and 1-aminopyrene administered by gavage to Sprague-Dawley rats. Cancer Res. 48: 4256-4260.
121. El-Bayoumy K, Rivenson A, Upadhyaya P, Chae YH and Hecht SS (1993) Induction of mammary cancer by 6-nitrochrysene in female CD rats. Cancer Res. 53: 3719-3722.
122. El-Bayoumy K, Chae CH, Upadhyaya P, Rivenson A, Kurtzke C, Reddy B and Hecht SS (1995) Comparative tumorigenicity of benzo[a]pyrene, 1- nitropyrene and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine administered by gavage to female CD rats. Carcinogenesis 16: 431-434.
123. El-Bayoumy K, Desai D, Boyiri T, Rosa J, Krzeminski J, Sharma AK, Pittman B and Amin S (2002) Comparative tumorigenicity of the environmental pollutant 6-nitrochrysene and its metabolites in the rat mammary gland. Chem. Res. Toxicol. 15: 972-978.
124. Hecht SS, Amin S, Lin YM, Rivenson A, Kurtzke C and El-Bayoumy K (1995) Mammary carcinogenicity of fluoranthene, a commonly occurring environmental pollutant. Carcinogenesis 16: 1433-1435.
125. Hirose M, Lee MS, Wang CY and King CM (1984) Induction of rat mammary gland tumors by 1-nitropyrene, a recently recognized environmental mutagen. Cancer Res. 44: 1158-1162.
126. Imaida K, Hirose M, Tay L, Lee MS, Wang CY and King CM (1991) Comparative carcinogenicities of 1-, 2-, and 4-nitropyrene and structurally related compounds in the female CD rat. Cancer Res. 51: 2902-2907.
127. Imaida K, Lee MS, Wang CY and King CM (1991) Carcinogenicity of di- nitropyrenes in the weanling female CD rat. Carcinogenesis 12:1187-1191.
128. Miller JA, Sandin RB, Miller EC and Rusch HP (1955) The carcinogenicity of compounds related to 2-acetylaminofluorene. II. Variations in the bridges and the 2-substituent. Cancer Res. 15: 188-199.
129. Miller EC, Fletcher TL, Margreth A and Miller JA (1962) The carcinogenicities of derivatives of fluorine and biphenyl: fluoro derivatives as probes for active sites in 2-acetylaminofluorene. Cancer Res. 22: 1002-1014.
130. Takemura N, Hashida C and Terasawa M (1974) Carcinogenic action of 5- nitroacenaphthanene. Br. J. Cancer 30: 481-483.
131. Guengerich FP (2000) Metabolism of chemical carcinogens. Carcinogenesis 21: 345-351.
132. Purohit V and Basu AK (2000) Mutagenicity of nitroaromatic compounds. Chem. Res. Toxicol. 13: 673-692.
133. Van BekkumY (1999) Occupational exposure to diesel exhaust in a confined indoor workplace: application of multiple methods for monitoring, using 1- nitropyrene as a biomarker. In: Biomonitoring of Exposure to Diesel Exhaust (Chapter 6 of PhD Thesis, pp 141-164) University of Nijmegen, Nijmegen, The Netherlands.
134. Boyiri T, Leszczynska J, Desai D, Amin S, Nixon DW and El-Bayoumy K (2002) Metabolism and DNA binding of the environmental pollutant 6- nitrochrysene in primary culture of human breast cells and in cultured MCF-10A, MCF-7 and MDA-MB-435s cell lines. Int. J. Cancer 100: 395-400.
135. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y and Sutter T (1998) Differential expression of CYPlAl and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19: 291-298.
136. Iwanari M, Nakajima M, Kizu R, Hayakawa K andYokoi T (2002) Induction of CYPlAl, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch. Toxicol. 76: 287-298.